ANGELA FELTZ: Open Payments
NPI 1851502785 · FENTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 46 payments from 14 companies in 2025. Trend: 2023 $1,161 · 2024 $897 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $151 |
| PFIZER INC. | 8 | $146 |
| Novo Nordisk Inc | 6 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| Astellas Pharma US Inc | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Exact Sciences Corporation | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: Wegovy, QULIPTA, VRAYLAR, AIRSUPRA, INGREZZA, Veozah, NURTEC ODT, REXULTI.
Industry payments across MI — which companies pay providers there.
